Study of laboratory and clinical findings in patients with polycystic ovary syndrome
| dc.contributor.author | Büyük, Musa | |
| dc.contributor.author | Karacar Büyük, Nagihan | |
| dc.contributor.author | Suman, Kamuran | |
| dc.contributor.author | Kuşcu, Havva | |
| dc.contributor.author | Gök, Ebru | |
| dc.contributor.author | Suman, Murat | |
| dc.date.accessioned | 2023-10-16T13:28:16Z | |
| dc.date.available | 2023-10-16T13:28:16Z | |
| dc.date.issued | 2023 | en_US |
| dc.department | Altınbaş Üniversitesi | en_US |
| dc.description.abstract | Background/aim: To study blood parameters and clinical features of patients with polycystic ovary syndrome (PCOS). Materials and methods: We retrospectively studied 200 patients diagnosed with PCOS admitted to the Obstetrics and Gynecology Outpatient Department of Afyon State Hospital between March 2019 and June 2021. We noted the complaints of the outpatient clinic also their body mass indexes, the presence of insulin resistance according to the Homeostatic Model Assessment (HOMA) index, and their hormone profiles. Results: The mean age of the PCOS patients was 25.0±4.3 years, and the mean body mass index was 24.8±3.7 kg/height (m2). According to HOMA (n=31), 31% of patients have insulin resistance. Female patients frequently visited the clinic because of menstrual irregularities. Elevated prolactin levels were noted in 15% of patients. thyroid-stimulating hormone levels are elevated in 10% of the patients. Conclusion: Polycystic ovary syndrome is a genetic problem and may have clinical symptoms with insulin resistance. Patients have gynecological symptoms and metabolic changes. Patients diagnosed with PCOS should be fully informed and educated about the risks that may occur during their lifetime. Additional to medical treatment, patients should exercise and have a proper diet. | en_US |
| dc.identifier.citation | Byük, M., Karacar Büyük, N., Suman, K., Kuşcu, H., Gök, E., Suman, M. (2023). Study of laboratory and clinical findings in patients with polycystic ovary syndrome. AURUM Journal of Health Sciences, 5(1), 3-8. | en_US |
| dc.identifier.endpage | 8 | en_US |
| dc.identifier.issn | 1234-5678 | |
| dc.identifier.issue | 1 | en_US |
| dc.identifier.startpage | 3 | en_US |
| dc.identifier.uri | https://hdl.handle.net/20.500.12939/4131 | |
| dc.identifier.volume | 5 | en_US |
| dc.language.iso | en | |
| dc.publisher | Altınbaş Üniversitesi | en_US |
| dc.relation.ispartof | AURUM Journal of Health Sciences | |
| dc.relation.publicationcategory | Makale - Ulusal Hakemli Dergi - Başka Kurum Yazarı | en_US |
| dc.rights | info:eu-repo/semantics/openAccess | en_US |
| dc.subject | Insulin Resistance | en_US |
| dc.subject | Metabolic Disease | en_US |
| dc.subject | Polycystic Ovarian Syndrome | en_US |
| dc.title | Study of laboratory and clinical findings in patients with polycystic ovary syndrome | |
| dc.type | Article |
